Mereo BioPharma Group plc
MREO
$2.30
$0.177.98%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 21.56% | 50.46% | 63.37% | -28.63% | -15.78% |
| Total Receivables | -11.08% | -- | -85.20% | -- | 35.63% |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -66.05% | -- | 0.59% | -- | -74.30% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -17.41% | -- | -- | -- | 142.04% |
| Total Current Assets | 17.26% | -- | 36.32% | -- | -15.21% |
|
|
|||||
| Total Current Assets | 17.26% | -- | 36.32% | -- | -15.21% |
| Net Property, Plant & Equipment | -40.36% | -- | -33.48% | -- | -25.54% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -40.96% | -- | -97.26% | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | 14.87% | -- | -6.19% | -- | -14.10% |
|
|
|||||
| Total Accounts Payable | 14.02% | -- | 44.29% | -- | -32.82% |
| Total Accrued Expenses | -20.41% | -- | -1.05% | -- | 1.93% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 857.36% | -- | -5.55% | -- | -95.31% |
| Total Finance Division Other Current Liabilities | -51.82% | -- | -95.68% | -- | -45.31% |
| Total Other Current Liabilities | -51.82% | -- | -95.68% | -- | -45.31% |
| Total Current Liabilities | 45.98% | -- | -30.29% | -- | -61.08% |
|
|
|||||
| Total Current Liabilities | 45.98% | -- | -30.29% | -- | -61.08% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -79.36% | -- | -55.36% | -- | -38.74% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 17.86% | -- | 44.25% | -- | 649.04% |
| Total Liabilities | -3.39% | -- | -39.92% | -- | -38.63% |
|
|
|||||
| Common Stock & APIC | 11.01% | -- | 63.21% | -- | 2.06% |
| Retained Earnings | -10.31% | -- | -1.37% | -- | -3.72% |
| Treasury Stock & Other | -0.72% | -- | -110.23% | -- | 18.71% |
| Total Common Equity | 20.64% | -1.15% | 7.18% | -16.66% | -1.68% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 20.64% | -1.15% | 7.18% | -16.66% | -1.68% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 20.64% | -1.15% | 7.18% | -16.66% | -1.68% |
|
|
|||||